For research use only. Not for therapeutic Use.
(S,R)-GSK321（Cat No.:I042949）is a selective small molecule inhibitor developed to target specific enzymes or proteins involved in cellular signaling pathways, particularly those linked to cancer and metabolic diseases. It is known for its ability to modulate key molecular targets that regulate cell growth, survival, and apoptosis. By inhibiting these pathways, (S,R)-GSK321 shows promise in disrupting tumor progression and improving the efficacy of cancer treatments. Researchers are investigating its potential therapeutic applications in oncology, aiming to enhance targeted therapies and provide new treatment options for various malignancies.
| CAS Number | 1816272-18-0 |
| Synonyms | (7S)-1-[(4-fluorophenyl)methyl]-N-[3-[(1R)-1-hydroxyethyl]phenyl]-7-methyl-5-(1H-pyrrole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide |
| Molecular Formula | C28H28FN5O3 |
| Purity | ≥95% |
| IUPAC Name | (7S)-1-[(4-fluorophenyl)methyl]-N-[3-[(1R)-1-hydroxyethyl]phenyl]-7-methyl-5-(1H-pyrrole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide |
| InChI | InChI=1S/C28H28FN5O3/c1-17-14-33(28(37)24-7-4-12-30-24)16-23-25(27(36)31-22-6-3-5-20(13-22)18(2)35)32-34(26(17)23)15-19-8-10-21(29)11-9-19/h3-13,17-18,30,35H,14-16H2,1-2H3,(H,31,36)/t17-,18+/m0/s1 |
| InChIKey | IVFDDVKCCBDPQZ-ZWKOTPCHSA-N |
| SMILES | C[C@H]1CN(CC2=C1N(N=C2C(=O)NC3=CC=CC(=C3)[C@@H](C)O)CC4=CC=C(C=C4)F)C(=O)C5=CC=CN5 |
